Man Group
LGND icon

Man Group’s Ligand Pharmaceuticals LGND Stock Holding History

Man Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,644
Closed -$1.13M – 2485
2026
Q1 		$1.13M Buy
5,644
+2,194
+64% +$434K ﹤0.01% 1790
2025
Q4 		$652K Buy
+3,450
New +$663K ﹤0.01% 1815
2024
Q2 		– Sell
-68,657
Closed -$5.02M – 2153
2024
Q1 		$5.02M Sell
68,657
-75,780
-52% -$5.59M 0.01% 994
2023
Q4 		$10.3M Buy
+144,437
New +$8.52M 0.03% 638
2023
Q3 		– Sell
-146,160
Closed -$9.62M – 674
2023
Q2 		$10.5M Buy
+146,160
New +$11M 0.03% 609
2023
Q1 		– Sell
-113,079
Closed -$8.04M – 548
2022
Q4 		$7.55M Sell
113,079
-50,106
-31% -$3.26M 0.03% 682
2022
Q3 		$8.77M Buy
+163,185
New +$9.59M 0.04% 516
2022
Q2 		– Hold
0
– – – 785
2021
Q2 		– Sell
-5,359
Closed -$510K – 2030
2021
Q1 		$510K Sell
5,359
-95,414
-95% -$9.02M ﹤0.01% 1472
2020
Q4 		$6.25M Sell
100,773
-85,734
-46% -$4.89M 0.03% 674
2020
Q3 		$11.1M Buy
186,507
+117,613
+171% +$8.02M 0.04% 433
2020
Q2 		$4.81M Buy
68,894
+12,962
+23% +$822K 0.02% 686
2020
Q1 		$2.54M Sell
55,932
-201,906
-78% -$11.4M 0.02% 796
2019
Q4 		$16.8M Buy
257,838
+90,727
+54% +$6.06M 0.06% 423
2019
Q3 		$10.4M Sell
167,111
-14,422
-8% -$905K 0.04% 572
2019
Q2 		$12.9M Buy
181,533
+115,243
+174% +$8.49M 0.05% 515
2019
Q1 		$5.2M Sell
66,290
-46,532
-41% -$3.53M 0.02% 897
2018
Q4 		$9.55M Sell
112,822
-8,592
-7% -$916K 0.04% 472
2018
Q3 		$20.8M Sell
121,414
-70,799
-37% -$10.7M 0.08% 308
2018
Q2 		$24.8M Sell
192,213
-71,000
-27% -$7.92M 0.1% 205
2018
Q1 		$27.1M Buy
+263,213
New +$26M 0.12% 167

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group's LGND Position: Q2 2026 in Review

Man Group sold out of Ligand Pharmaceuticals (LGND) in Q2 2026, closing a stake of 5,644 shares — an estimated $1.13M sold.

Man Group first reported a position in LGND in Q1 2018 and held it in 20 quarters. The position peaked at $27.1M in Q1 2018. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Man Group reported no remaining Ligand Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Man Group sold 5,644 Ligand Pharmaceuticals shares in Q2 2026, an estimated $1.13M.
  • Man Group first reported a position in Ligand Pharmaceuticals in Q1 2018 and held it in 20 quarters.
  • Man Group's Ligand Pharmaceuticals position peaked at $27.1M in Q1 2018.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.